Status | Study |
Completed |
Study Name: The Parkinson's Genetic Research Study Condition: Parkinson's Disease Date: 2012-03-16 |
Completed |
Study Name: A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease Condition: Huntington's Disease Date: 2011-11-29 Interventions: Drug: SEN0014196 100 mg, immediate release tablets, once daily administration |
Completed |
Study Name: An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196 Condition: Huntington Disease Date: 2011-11-29 Interventions: Drug: SEN0014196 (Low Dose) 10 |
Completed |
Study Name: Cellcept for Treatment of Juvenile Neuronal Ceroid Lipofuscinosis Condition: Juvenile Neuronal Ceroid Lipofuscinosis Date: 2011-07-05 Interventions: Drug: Mycophenolate mofetil Th |
Recruiting |
Study Name: AAVRh.10 Administered to Children With Late Infantile Neuronal Ceroid Lipofuscinosis Condition: Late Infantile Neuronal Ceroid Lipofuscinosis Batten Disease Date: 2010-12-13 Interventions: Biological: AAVrh.10CUCLN2 There will be 2 dose cohorts in this study. Group A consists of 2 subjects wh |
Withdrawn |
Study Name: Safety and Efficacy Study of HuCNS-SC in Subjects With Neuronal Ceroid Lipofuscinosis Condition: Neuronal Ceroid Lipofuscinosis Date: 2010-11-05 Interventions: Biological: HuCNS-SC Surgery to implant human CNS stem cells |
Recruiting |
Study Name: Safety Study of a Gene Transfer Vector (Rh.10) for Children With Late Infantile Neuronal Ceroid Lipofuscinosis Condition: Batten Disease Late-Infantile Neuronal Ceroid Lipofuscinosis Date: 2010-03-22 Interventions: Genetic: AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies |
Recruiting |
Study Name: Genotype-Phenotype Correlations of Late Infantile Neuronal Ceroid Lipofuscinosis Condition: Batten Disease Late Infantile Neuronal Ceroid Lipofuscinosis Date: 2009-12-16 |
Completed |
Study Name: Genetic Disease Gene Identification Condition: Congenital Vertical Talus Familial Encephalopathy With Neuroserpin Inclusion Bodies Date: 2009-06-08 |
Completed |
Study Name: Effect of Ropinirole Hydrochloride in Progressive Myoclonic Epilepsy of Unverricht-Lundborg Type Condition: Unverricht-Lundborg Syndrome Date: 2008-02-28 Interventions: Drug: Ropinirole 8 + 8 weeks cross-over placebo controlled |